VC firm

Alix Ventures

Kingmaker Tier

Kingmaker Tier: 82 out of 100

Record updated 17 September 2026

About

Supporting early stage Life Science startups engineering biology to drive radical advances in human health

Thesis: Life Sciences is experiencing rapid innovation with the rise of new generation of companies known as “TechBio” (Melding Technology & Biology), a change we believe is leading to some of the most impactful solutions in decades. Our passion is to help build transformative companies ahead of this revolution to significantly impact the quality & effectiveness of patient care. We aim to partner with passionate, accomplished founders who possess unique insights to solve some of the world’s most daring problems facing us in Life Sciences.Source (opens in a new tab)
Reserves policy: Yes, we are thrilled to invest in the follow on rounds of our portfolio companies, we specifically reserve capital (50% of our fund) to do so, as well as aim for $1 - 2M in SPVs for Series As & $5 - 10M for Series Bs.
Eligibility: We're very interested in platform companies more broadly speaking across human health regardless if they enable applications or infrastructure, but besides a select few anti-theses we don't limit our investments to any specific verticals within life sciences. As long as there's a patient focus & a chance to build a massive business while solving a big problem in the world, it's exciting to us!
Investing status notes: We back companies at the earliest stages (Pre-Seed, Seed, & select Series As) usually raising their first institutional round of funding.

VC Catalog has relationship data for this record. Sign in with Google to explore it on the interactive map.